Witold Wrona

Valuation of EQ-5D Health States in Poland: First TTO-Based Social Value Set in Central and Eastern Europe

Dominik Golicki, Michał Jakubczyk, Maciej Niewada et al. · Value in Health · 2009 · 115 citations · Full text

Pharmacy, Health Policy, Pharmacoeconomics +16

Self-assessed health status in Poland: EQ-5D findings from the Polish valuation study

Dominik Golicki, Maciej Niewada, Michał Jakubczyk et al. · Polskie Archiwum Medycyny Wewnętrznej · 2010 · 46 citations · Full text

Pharmacy, Health Sciences, Health Assessment +16

Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years

Aneta Mela, Łukasz A. Poniatowski, Bartłomiej Drop et al. · Frontiers in Pharmacology · 2020 · 29 citations · Full text

Public Affairs, Pharmaceutical Policy, Pharmacoeconomics +17

Indirect costs of back pain – Review

Agnieszka Tymecka-Woszczerowicz, Witold Wrona, Piotr Kowalski et al. · Polish Annals of Medicine · 2015 · 21 citations

Pharmacy, Orthopaedic Surgery, Benefit-cost Analysis +15

The direct and indirect costs of epilepsy in Poland estimates for 2014–2016 years

Aneta Mela, Anna Staniszewska, Witold Wrona et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2018 · 11 citations

Health Professions, Health Systems, Pharmacoeconomics +13